InvestorsHub Logo
Followers 0
Posts 50
Boards Moderated 0
Alias Born 10/15/2011

Re: None

Saturday, 07/14/2012 7:18:38 PM

Saturday, July 14, 2012 7:18:38 PM

Post# of 19
Finally, here is a link to a recent news release from Miraculins, highlighting the fact that Alere has chosen to renew their final 6-month option period for testing Miraculins biomarkers.

Alere Secures Final Option Period on Miraculins Preeclampsia Technology

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.